Research - Nanjing, Jiangsu, China
Biosynergics Inc. (BSI) is dedicated to the discovery and development of the innovative biologics for the unmet medical needs. With our proprietary H3 (High-throughput High-content High-efficiency) antibody platform and SynAbTM technology, BSI is committed to the development of biological molecules with superior drug properties and/or with novel mechanism of actions to known and novel drug targets.Based on our cutting-edge technology and proven-track records, together with our clients and partners, we are striving to bring innovative and affordable biologics to patients around the world.